Blog
17 Articles
![Dr. Gulam Manji](https://letswinpc.org/wp-content/uploads/2024/02/Gulam-Manji.jpg)
Chemotherapy Plus Immunotherapy Trial Shows Promise
Dr. Gulam Manji leads a clinical trial that uses two types of immunotherapy to enhance chemotherapy for pancreatic cancer patients.
![T lymphocyte in red on dark background](https://letswinpc.org/wp-content/uploads/2022/12/T_Lymphocyte_crop.jpg)
Testing a New Immunotherapy Combo in Advanced Pancreatic Cancer
Researchers are testing an approved immunotherapy drug with a new drug that works on T cells to make it more effective for pancreatic cancer.
![Dr. Allyson Ocean](https://letswinpc.org/wp-content/uploads/2022/10/Allyson_Ocean.jpg)
Surprising Clinical Trial Results in Pancreatic and Rectal Cancer
Let’s Win Scientific Advisory Board Chair Dr. Allyson Ocean explains the surprising clinical trial results in pancreatic and rectal cancers.
![Dr. Elizabeth Jaffee](https://letswinpc.org/wp-content/uploads/2022/10/Elizabeth-Jaffee.jpg)
New Clinical Accelerator Initiative Shortens Time from Bench to Clinic
Dr. Elizabeth Jaffee explains the importance of Lustgarten’s Clinical Accelerator Initiative to speed up the time from bench to trial.
![vaccine vial and syringe](https://letswinpc.org/wp-content/uploads/2022/09/ct2021oct27.jpg)
A Vaccine To Boost Immune Response to Pancreatic Cancer
Researchers are testing whether a vaccine can heighten the body’s immune response to pancreatic cancer after surgical removal of the tumor.
![Dr. William Freed-Pastor](https://letswinpc.org/wp-content/uploads/2022/10/Will-Freed-Pastor.jpg)
Triple Immunotherapy Shows Dramatic Results
Dr. William Freed-Pastor is testing a combination of three types of immunotherapy to attack pancreatic tumors.
![](https://letswinpc.org/wp-content/uploads/2022/09/ct2021jun21-1.jpg)
CRISPR-Engineered Immunotherapy for Metastatic GI Tract Cancers
CRISPR technology is used as part of an immunotherapy clinical trial for metastatic pancreatic cancer and other GI cancers.
![Dr. Beatriz Carreno](https://letswinpc.org/wp-content/uploads/2022/10/Beatriz-Carreno.jpg)
Targeting Mutant KRAS with Immunotherapy
Dr. Beatriz Carreno explains how her team is targeting the KRAS mutation with a pancreatic cancer vaccine to make the immune system work against cancer.
![Pancreatic Cancer Collective and Lustgarten logo and the Stand Up To Cancer logos](https://letswinpc.org/wp-content/uploads/2022/10/PCC-logo.gif)
Challenge Grant Recipients Moving Forward
The Pancreatic Cancer Collective awarded four teams a second round of New Therapies Challenge Grants, to further develop new pancreatic cancer treatment.
![Killer T cells](https://letswinpc.org/wp-content/uploads/2022/10/Killer-T-cells.jpg)
CAR T Cell Trial Targets Mesothelin
In an immunotherapy clinical trial, Dr. Mark O’Hara is using CAR T cells to attack mesothelin-expressing tumor cells in pancreatic cancer.
![Dr. Vinod Balachandran](https://letswinpc.org/wp-content/uploads/2022/10/Balachandran.jpg)
Pancreatic Cancer Exceptional Responders and the Immune System Link
Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.
![Deirdre Cohen](https://letswinpc.org/wp-content/uploads/2022/10/Deirdre-Cohen.jpg)
Aiming to Improve Immunotherapy for Pancreatic Cancer
Dr. Deirdre Cohen discusses clinical trials that aim to improve the effectiveness of immunotherapy for pancreatic cancer.
![Dr. Ben Z. Stanger](https://letswinpc.org/wp-content/uploads/2022/10/Stanger.jpg)
New Research Sheds Light on Hot and Cold Tumors
Dr. Ben Z. Stanger and his team are finding links between the number of T cells a tumor has and the effectiveness of immunotherapy.
![Dr. Vinod Balachandran](https://letswinpc.org/wp-content/uploads/2022/10/Balachandran.jpg)
Neoantigens Provide New Hope for Pancreatic Cancer Treatments
Vinod Balachandran’s team identified increased T cells in the tumors of long-term pancreatic cancer survivors, with a role for neoantigens in immunotherapy.